GlassScriptPhysician profile
Michal Senitko
NPI 1336378637
$184,643.48
in general payments reported to CMS, 2019-2025
42 companies · $26K in 2025
The $26K reported for 2025 was more than what 96% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,273 · 2020: $4,319 · 2021: $923 · 2022: $6,646 · 2023: $67K · 2024: $70K · 2025: $26K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $132K · Travel and Lodging: $16K · Food and Beverage: $10K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,400.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $132,000.00 |
| Travel and Lodging | $15,794.18 |
| Food and Beverage | $10,286.64 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,400.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $163,914.05 | 2019-2025 | Da Vinci Surgical System, Da Vinci Sp |
| Pinnacle Biologics, INC | $10,547.96 | 2019-2023 | Photofrin |
| Ethicon INC. | $1,962.96 | 2019-2022 | |
| Medtronic USA, INC. | $1,800.00 | 2020 | |
| Pulmonx Corporation | $1,790.87 | 2019-2025 | Zephyr Endobronchial Valve, Zephyr Delivery Catheter, Chartis Catheter |
| Pfizer INC. | $644.18 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $506.13 | 2019-2025 | Airsupra, Tagrisso, Fasenra |
| Veran Medical Technologies, INC. | $411.33 | 2019-2020 | |
| Abbvie INC. | $374.61 | 2021-2025 | Avycaz, Teflaro |
| Glaxosmithkline, LLC. | $337.74 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Actelion Pharmaceuticals US, INC. | $325.35 | 2020-2025 | Uptravi, Opsumit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $252.43 | 2019-2024 | Ofev |
| Csa Medical, INC | $243.51 | 2019 | |
| Mallinckrodt Hospital Products INC. | $168.74 | 2020-2024 | Acthar |
| Sunovion Pharmaceuticals INC. | $149.99 | 2019 |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| United Therapeutics Corporation | $137.88 | 2019-2025 | Tyvaso |
| Erbe USA INC | $128.13 | 2024 | Vio3 Cryo Apc |
| Astellas Pharma US INC | $102.12 | 2019-2022 | |
| Inari Medical, INC. | $93.23 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Regeneron Healthcare Solutions, INC. | $82.18 | 2024-2025 | Dupixent |
| Merck Sharp & Dohme LLC | $68.81 | 2020-2025 | Zerbaxa |
| Bard Access Systems, INC. | $67.43 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $60.73 | 2019-2021 | |
| Olympus America INC. | $59.15 | 2021-2023 | Olympus, Evis Exera II Ultrasonic Bronchofibervideoscope |
| Insmed, INC. | $42.98 | 2022-2025 | Arikayce |
| Gilead Sciences, INC. | $34.12 | 2019 | |
| Ambu INC. | $33.22 | 2025 | |
| Philips North America LLC | $31.22 | 2020 | |
| Grifols USA, LLC | $30.51 | 2023-2025 | Prolastin-C Liquid |
| Novartis Pharmaceuticals Corporation | $29.23 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $25.05 | 2025 | Glassia |
| La Jolla Pharmaceutical Company | $24.52 | 2019 | |
| Boston Scientific Corporation | $24.05 | 2022 | |
| Vapotherm INC | $23.62 | 2022 | |
| Baxter Healthcare | $20.97 | 2024 | Hillrom - Life 2000 Ventilation System |
| Mallinckrodt Enterprises LLC | $20.25 | 2019 | |
| Portola Pharmaceuticals, LLC | $17.52 | 2019 | |
| Verona Pharma, INC. | $15.24 | 2025 | Ohtuvayre |
| Bard Peripheral Vascular, INC. | $14.76 | 2021 | |
| Mylan Specialty L.P. | $14.62 | 2019 | |
| Tetraphase Pharmaceuticals, INC. | $12.09 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michal Senitko listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.